- What We Do
- Agriculture and Food Security
- Democracy, Human Rights and Governance
- Economic Growth and Trade
- Ending Extreme Poverty
- Environment and Global Climate Change
- Gender Equality and Women's Empowerment
- Global Health
- Cross-Cutting Areas
- Emerging Pandemic Threats
- Family Planning
- HIV and AIDS
- Health Systems Strengthening
- Maternal and Child Health
- Neglected Tropical Diseases
- Water and Sanitation
- Working in Crises and Conflict
- U.S. Global Development Lab
National Action Plan for Combating Multidrug-Resistant Tuberculosis: Six Month Progress Report and Forward Direction
The National Action Plan for Combating Multidrug-Resistant Tuberculosis (MDR-TB): Six Month Progress Report and Forward Direction is an interagency progress report that summarizes the activities undertaken during the first six months in support of the National Action Plan for Combating Multidrug-Resistant Tuberculosis.
Since January 2016, the U.S. Government agencies charged with implementing the plan have made progress toward achieving its three goals and corresponding objectives. The U.S. Government agencies implementing the National Action Plan (NAP) will continue working together to move priority activities forward over the next six months.
The first annual report for the NAP will be released on World Tuberculosis Day, March 24, 2017. This report will include a summary of milestones achieved under each goal.
Download the full report [PDF, 1.7MB].
National Action Plan for Combating MDR-TB Launch Event
January 7, 2016 from 10am-12pm
The Sphinx Club at Franklin Square, Washington, DC
The Obama administration announced on December 22, 2015 a comprehensive set of federal activities and a call to action to the global community to combat the rise of multidrug-resistant tuberculosis (MDR-TB).
The National Action Plan for Combating Multidrug-Resistant Tuberculosis, developed by an interagency working group in response to Executive Order 13676: Combating Antibiotic-Resistant Bacteria and the National Action Plan for Combating Antibiotic Resistant Bacteria, identifies a set of targeted interventions that address the core domestic and global challenges posed by MDR-TB and extensively drug-resistant TB (XDR-TB).
The recommended interventions represent the U.S. Government’s contributions to reversing the worldwide spread of MDR-TB and can help inform policy development processes around the world.
The National Action Plan is an effort to articulate a comprehensive strategy, and to mobilize political will and additional financial and in-kind commitments from bilateral and multilateral donor partners, private-sector partners, and governments of all affected countries.
- Read the press release announcing prominent health care companies partnering with USAID to combat drug-resistant tuberculosis.
- Watch a video message from Congressman Eliot Engel.
Last updated: October 06, 2016